The Middleby MIDD 深 沪
等待开盘 09-09 09:30:00 美东时间
108.63
-3.120
-2.79%
华盛通- 最 高112.85
- 今 开111.19
- 成交量 36.98万股
- 最 低 108.47
- 昨 收 111.75
- 总市值 49.13亿
- 52周最高 145.08
- 市盈率 静 --
- 换手率 0.82%
- 52周最低 75.77
- 委 比 91.17%
- 总股本 4522.23万
- 历史最高 166.29
- 量 比 0.84
- 振 幅 3.92%
- 历史最低 -13.2547
- 每 手 1
- 风险率 15.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
Canaccord Genuity Maintains Buy on Middleby, Raises Price Target to $160
Canaccord Genuity analyst Brian McNamara maintains Middleby (NASDAQ:MIDD) with a Buy and raises the price target from $157 to $160.
09-02 01:50
Here's How Much $1000 Invested In Middleby 20 Years Ago Would Be Worth Today
Middleby (NASDAQ:MIDD) has outperformed the market over the past 20 years by 3.27% on an annualized basis producing an average annual return of 12.51%. Currently, Middleby has a market capitalization of $5.16 billion. Buying $1000 In MIDD: If an investor had bought $1000 of MIDD stock 20 years ago, ...
08-28 22:45
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
财报速睇 | The Middleby 2026财年Q3营收8.76亿美元，同比增长9.9%；归母净利润0.55亿美元，同比下滑48.1%
华盛资讯8月14日讯，The Middleby公布2026财年Q3业绩，公司Q3营收8.76亿美元，同比增长9.9%，归母净利润0.55亿美元，同比下滑48.1%。
08-14 05:04
美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
Oppenheimer Maintains Outperform on Middleby, Lowers Price Target to $160
Oppenheimer analyst Ian Zaffino maintains Middleby (NASDAQ:MIDD) with a Outperform and lowers the price target from $205 to $160.
08-12 23:22
Middleby shares are trading lower after the company reported a sharp decline in Q2 net earnings and lowered its FY26 financial guidance.
Middleby shares are trading lower after the company reported a sharp decline in Q2 net earnings and lowered its FY26 financial guidance.
08-12 01:24
财报速睇 | The Middleby 2026财年Q2营收8.76亿美元，同比增长9.9%；归母净利润0.55亿美元，同比下滑48.1%
华盛资讯8月11日讯，The Middleby公布2026财年Q2业绩，公司Q2营收8.76亿美元，同比增长9.9%，归母净利润0.55亿美元，同比下滑48.1%。
08-11 19:18
Middleby Sees Q3 Adj EPS $1.67-$1.83 vs $1.71 Est; Sees Sales $620.000M-$640.000M vs $624.150M Est
Middleby (NASDAQ:MIDD) is looking for Q3 Adj EPS of $1.67-$1.83 vs $1.71 analyst estimate. sees sales of $620.000 million-$640.000 million vs $624.150 million analyst estimate.
08-11 19:03
